Seneschal Advisors
IDXX icon

Seneschal Advisors’s Idexx Laboratories IDXX Stock Holding History

Seneschal Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$523 Hold
1
– – ﹤0.01% 414
2026
Q2 		$527 Hold
1
– – ﹤0.01% 389
2026
Q1 		$562 Hold
1
– – ﹤0.01% 338
2025
Q4 		$677 Hold
1
– – ﹤0.01% 288
2025
Q3 		$639 Buy
+1
New +$607 ﹤0.01% 305

Other funds holding IDXX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Seneschal Advisors's IDXX Position: Q3 2026 in Review

Seneschal Advisors held its Idexx Laboratories (IDXX) position steady in Q3 2026 at 1 share worth $523. The position accounts for ﹤0.01% of the portfolio, ranked #414.

Seneschal Advisors first reported a position in IDXX in Q3 2025 and has held it in 5 quarters since. The position peaked at $677 in Q4 2025. 1,073 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Seneschal Advisors held 1 share of Idexx Laboratories worth $523 as of Q3 2026.
  • Seneschal Advisors left its Idexx Laboratories share count unchanged in Q3 2026.
  • Idexx Laboratories made up ﹤0.01% of Seneschal Advisors's portfolio in Q3 2026, its #414 holding.
  • Seneschal Advisors first reported a position in Idexx Laboratories in Q3 2025 and has held it in 5 quarters since.
  • Seneschal Advisors's Idexx Laboratories position peaked at $677 in Q4 2025.
  • 1,073 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Seneschal Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.